Cargando…
The Impact of Serotype Cross-Protection on Vaccine Trials: DENVax as a Case Study
There is a growing public health need for effective preventive interventions against dengue, and a safe, effective and affordable dengue vaccine against the four serotypes would be a significant achievement for disease prevention and control. Two tetravalent dengue vaccines, Dengvaxia (CYD-TDV—Sanof...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7711858/ https://www.ncbi.nlm.nih.gov/pubmed/33198303 http://dx.doi.org/10.3390/vaccines8040674 |